Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

53
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

140
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
140
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

40
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
40
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

46
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
46
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

566
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
566
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

236
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
236

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney Disease and Sars-coV-2 Infection: Challenges and Considerations for Nursing.

Critical care nursing clinics of North America·2022
Same author

Transitions of Care Considerations for Nephrology Patients.

Critical care nursing clinics of North America·2022
Same author

Critical care nursing clinics of North America·2022
Same author

Identifying and Eliminating the Barriers to Patient Education for Patients in the Early Stages of Chronic Kidney Disease.

Nephrology nursing journal : journal of the American Nephrology Nurses' Association·2017

Related Experiment Video

Updated: Aug 23, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

Principles for the Prevention of Medication-Induced Nephrotoxicity.

Sherry Rivera1

  • 1Louisiana State University Health New Orleans, School of Nursing, 1900 Gravier Street, Room 4A6, New Orleans, LA 70112, USA.

Critical Care Nursing Clinics of North America
|November 6, 2022
PubMed
Summary

Medications frequently harm kidneys, worsening disease and increasing costs. Careful prescribing and nephrotoxic stewardship are crucial for preventing acute kidney injury and end-stage kidney disease.

Keywords:
Acute kidney injuryChronic kidney injuryKidney diseaseMedication-induced kidney diseaseNephrotoxic medications

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.0K

Related Experiment Videos

Last Updated: Aug 23, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.5K
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

17.0K

Area of Science:

  • Nephrology
  • Pharmacology
  • Clinical Practice Guidelines

Background:

  • Medications are a significant cause of kidney injury, contributing to disease progression, adverse outcomes, and elevated healthcare expenses.
  • Potentially nephrotoxic medications are widely used by patients with kidney disease, leading to poorer health outcomes.
  • Medication-induced nephrotoxicity is a substantial contributor to acute kidney injury (AKI) in both adult and pediatric populations.

Purpose of the Study:

  • To highlight the prevalence and impact of medication-induced nephrotoxicity in patients with kidney disease.
  • To emphasize the importance of improved prescribing practices and nephrotoxic stewardship in preventing kidney injury.
  • To underscore the recommendations from KDIGO Clinical Practice Guidelines regarding cautious prescribing for at-risk patients.

Main Methods:

  • Review of existing literature and clinical practice guidelines concerning medication-induced nephrotoxicity.
  • Analysis of data on the utilization of potentially nephrotoxic medications in individuals with kidney disease.
  • Examination of the incidence of adverse drug events and acute kidney injury attributed to nephrotoxic medications.

Main Results:

  • Over 50-72% of individuals with kidney disease use potentially nephrotoxic medications, correlating with poorer outcomes.
  • Annually, approximately 1.5 million adverse drug events related to medication-induced nephrotoxicity occur in the US.
  • Medication-induced nephrotoxicity accounts for 14-26% of AKI cases in adults and 16% in hospitalized children.

Conclusions:

  • There is a critical need for enhanced nephrotoxic stewardship among healthcare providers, including nurses.
  • Implementing improved prescribing practices can significantly reduce the incidence of acute kidney injury and progression to end-stage kidney disease.
  • Adherence to KDIGO guidelines for cautious prescribing is essential for mitigating medication-related kidney damage.